Question explored with the scientific record
Astaxanthin
The short version: astaxanthin shows real but narrow effects on oxidative stress and exercise recovery in small human trials, with no long-term safety data and no studies comparing it head-to-head against a true placebo for hard clinical outcomes like death or hospitalization.
The evidence for astaxanthin comes from small, short-term human trials and animal studies. A 2025 crossover trial in 14 young men found that 28 mg/day for 4 days improved cycling time to exhaustion by about 13 minutes and lowered muscle damage markers like CK and LDH, but did not change inflammation or antioxidant capacity [1]. A 2013 trial in trained cyclists found no improvement in fat use or endurance performance after 4 weeks of supplementation [2]. A 2025 trial in 90 women with type 2 diabetes found that 8 mg/day for 8 weeks, combined with exercise, reduced oxidative stress and inflammation markers [3]. A 2017 before-after study in 31 middle-aged adults found that 4 mg/day for 4 weeks lowered plasma MDA and improved some skin surface measures, but it had no placebo group and was funded by the supplement company [5].
The mechanistic picture from animal studies is broader. In diabetic rats, astaxanthin lowered IL-6, TNF-α, and MDA [7]. In mouse models of obesity, it reduced liver inflammation and fibrosis [8]. In mice, it enhanced antibody production to T-dependent antigens, especially in young animals [11]. In mouse IVF, adding astaxanthin to fertilization medium increased fertilization rates, but adding it to embryo culture medium impaired blastocyst development [6]. In broiler chickens under heat stress, 40-80 ppm in feed improved antioxidant capacity and meat color [9]. In pigs, 66.7 mg/kg in feed for 42 days darkened pork color and reduced purge loss, with a non-significant trend toward lower lipid oxidation [4].
What is missing is the most important thing: long-term human safety data. The longest human trial here is 8 weeks. No study tracks adverse events beyond the intervention period. No study compares astaxanthin users to non-users for all-cause mortality, cancer, autoimmune disease, or any hard clinical endpoint. The supplement industry funds most of the research, and the largest human trial had 90 participants. The burden of proof for a daily supplement taken for years has not been met.
| Outcome | What the evidence shows | Confidence |
|---|---|---|
| Exercise endurance (young men) | ~13 min improvement in time to exhaustion after 4 days at 28 mg/day [1] | Moderate (single small trial) |
| Fat oxidation or endurance (trained cyclists) | No improvement after 4 weeks [2] | Moderate (one trial) |
| Oxidative stress markers (type 2 diabetes) | Reduced MDA, improved TAC, SOD, GPx after 8 weeks at 8 mg/day with exercise [3] | Moderate (one trial) |
| Skin surface changes (middle-aged) | Reduced MDA, improved corneocyte desquamation after 4 weeks at 4 mg/day [5] | Low (no placebo, funder conflict) |
| Liver enzymes (climacteric women) | Decreased AST, ALT after supplementation [10] | Low (preliminary data only) |
| Long-term safety | Not studied in humans | Not clear |
My call: astaxanthin may reduce oxidative stress and improve exercise recovery in the short term, but the evidence base is too thin and too short to recommend daily supplementation for general health. The long-term effects are unknown. Confidence: low.
Sources used 11
-
Effect of astaxanthin supplementation on cycling performance, muscle damage biomarkers and oxidative stress in young adults: a randomized controlled trial
This randomized crossover trial in young, healthy adult males tested whether short-term astaxanthin supplementation (28 mg/day for 4 days) enhances cycling endurance and mitigates exercise-induced muscle damage and oxidative stress; it found improved time to exhaustion and reduc…
DOI: 10.1186/s13102-025-01221-3 -
Astaxanthin Supplementation Does Not Augment Fat Use or Improve Endurance Performance
This study investigates the effects of astaxanthin supplementation on fat oxidation and endurance performance in trained cyclists, finding no significant improvements in either parameter after four weeks of supplementation.
DOI: 10.1249/mss.0b013e31827fddc4 -
Redox-sensitive miRNAs and Humanin could mediate effects of exercise and astaxanthin on oxidative stress and inflammation in type 2 diabetes
In women with type 2 diabetes, eight weeks of concurrent aerobic+resistance training and/or astaxanthin supplementation, alone or combined, reduced oxidative stress and inflammation through modulation of Humanin and specific microRNAs, with the combination yielding the strongest…
DOI: 10.1038/s41598-025-23914-y -
Fresh Pork Quality and Shelf-Life Characteristics of Meat from Pigs Supplemented with Natural Astaxanthin in the Diet
Dietary astaxanthin supplementation at 66.7 mg/kg for 42 d darkened and reddened pork color during retail display and reduced purge loss after 14 d of storage, with no effect on growth or fabrication lean quality.
DOI: 10.15232/s1080-7446(15)30554-4 -
Continuous astaxanthin intake reduces oxidative stress and reverses age-related morphological changes of residual skin surface components in middle-aged volunteers
A four-week daily astaxanthin supplementation (4 mg/day) in middle-aged adults reduced systemic oxidative stress (lower plasma malondialdehyde) and reversed several age-related residual skin surface component (RSSC) changes on facial skin, as assessed by non-invasive sampling an…
DOI: 10.1016/j.nutres.2017.10.006 -
Effects of astaxanthin supplementation in fertilization medium and/or culture medium on the fertilization and development of mouse oocytes
Astaxanthin supplementation in fertilization medium increases fertilization rates of mouse oocytes, while supplementation in embryo culture medium impairs blastocyst development; overall, adding AST only to the fertilization medium yields the best blastocyst formation and qualit…
DOI: 10.5653/cerm.2021.04770 -
Anticoagulatory and Antiinflammatory Effects of Astaxanthin in Diabetic Rats
The study investigates the anticoagulatory and anti-inflammatory effects of astaxanthin in diabetic rats, demonstrating its potential to reduce oxidative stress and improve hemostatic balance.
DOI: 10.1111/j.1750-3841.2011.02558.x -
Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis
This study investigates the effects of astaxanthin on inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis, demonstrating its potential to mitigate metabolic abnormalities associated with these conditi…
DOI: 10.1016/j.jnutbio.2016.01.006 -
Muscle Antioxidant Activity and Meat Quality Are Altered by Supplementation of Astaxanthin in Broilers Exposed to High Temperature
This study evaluates dose-dependent dietary astaxanthin (0, 20, 40, 80 ppm) on antioxidant status, immune/gene expression, and meat quality in heat-stressed broiler chickens, finding improved antioxidant capacity, reduced stress/inflammatory markers, and enhanced meat color and …
DOI: 10.3390/antiox9111032 -
Effects of Astaxanthin on Liver and Leukocyte Parameters in Healthy Climacteric Women: Preliminary Data
This study investigates the effects of astaxanthin supplementation on liver and leukocyte parameters in healthy climacteric women, revealing a significant decrease in liver enzymes and an unexpected increase in blood leukocytes.
DOI: 10.1089/jmf.2016.3819 -
Immunomodulating actions of carotenoids: Enhancement of in vivo and in vitro antibody production to T‐dependent antigens
This study investigates the immunomodulating effects of carotenoids, specifically astaxanthin, lutein, and β-carotene, on antibody production in response to T-dependent antigens in both young and old B6 mice, revealing that these carotenoids enhance antibody production while the…
DOI: 10.1080/01635589409514303